GPS and Rare Lung Diseases (RLDs): an ERS statement  for the development of RLD guidelines for general practice 

Bruno Balbi (Veruno, Italy)

Source: International Congress 2016 – ERS statements and technical standards
Session: ERS statements and technical standards
Session type: Session
Number: 1963

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Bruno Balbi (Veruno, Italy). GPS and Rare Lung Diseases (RLDs): an ERS statement  for the development of RLD guidelines for general practice . International Congress 2016 – ERS statements and technical standards

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The Global Lung Function Initiative (GLI) Network ERS Clinical Research Collaboration: how international collaboration can shape clinical practice
Source: Eur Respir J, 53 (2) 1802277; 10.1183/13993003.02277-2018
Year: 2019



European Respiratory Society clinical practice guidelines: methodological guidance
Source: ERJ Open Res, 8 (1) 00655-2021; 10.1183/23120541.00655-2021
Year: 2022



The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration
Source: Eur Respir J, 52 (6) 1801855; 10.1183/13993003.01855-2018
Year: 2018



Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline - ERS pocket guideline
Source: Guideline 2017
Year: 2017

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Source: Eur Respir J 2015; 46: 903-975
Year: 2015



An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
Source: Eur Respir J 2015; 46: 976-987
Year: 2015



Electronic cigarette use in youths: a position statement of the Forum of International Respiratory Societies
Source: Eur Respir J, 51 (5) 1800278; 10.1183/13993003.00278-2018
Year: 2018



The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research
Source: Eur Respir J, 52 (5) 1801671; 10.1183/13993003.01671-2018
Year: 2018



Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease
Source: Eur Respir J 2016; 47:1345-1347
Year: 2016


International ERS/ATS Guidelines on Definition, Evaluation and Treatment of Severe Asthma
Source: Guideline 2014
Year: 2014


The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis
Source: Eur Respir J, 53 (5) 1900539; 10.1183/13993003.00539-2019
Year: 2019



Key paediatric messages from the 2016 European Respiratory Society International Congress
Source: ERJ Open Res, 3 (1) 00127-2016; 10.1183/23120541.00127-2016
Year: 2017



Respiratory Critical Care HERMES: European curriculum recommendations
Source: Breathe 2014; 10: 15-22
Year: 2014


Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)
Source: Eur Respir Rev, 29 (157) 200287; 10.1183/16000617.0287-2020
Year: 2020



European Respiratory Society Guidelines on the use of nebulizers: Guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers
Source: Eur Respir J 2001; 18: 228-242
Year: 2001


Collaboration with non-profit organization, EPAREC (Expert Patient in Respiratory Care) in disseminating asthma management plan
Source: Eur Respir J 2006; 28: Suppl. 50, 738s
Year: 2006

Insights into the process used to develop the Official 2015 ATS/ERS/JRS/ALAT Clinical Practice Guidelines: Treatment of Idiopathic Pulmonary Fibrosis – An Update of the 2011 Clinical Practice Guideline
Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis
Year: 2015

GPs Meet Rare Lung Disorders Task Force factsheet: childhood interstitial lung disease
Source: Breathe 2014; 10:173-175
Year: 2014



Screening for COPD using the Canadian Lung Association questionnaire: A practice assessment of Canadian physicians
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010


Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration
Source: Eur Respir J 2016; 48: 632-647
Year: 2016